tm logo
VECTURA V
Dead/Cancelled
CANCELLED – SECTION 71

on 30 Aug 2024

Last Applicant/ Owned by

Chippenham, Wiltshire SN14 6FH

GB

Serial Number

79204968 filed on 03rd Nov 2016

Registration Number

5398606 registered on 13th Feb 2018

in the Principal Register

Correspondent Address

Molly B. Markley

Molly B. Markley Young Basile Hanlon & MacFarlane P.C.

Suite 624

Troy, MI 48084-3107

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

VECTURA V

Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing Medical apparatus and instruments, namely drug delivery d Read More

Classification Information


Class [010]
Medical Instrument Products


Medical apparatus and instruments, namely drug delivery devices, namely drug delivery systems; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical and biological preparations for medical purposes, namely for the treatment of diseases or conditions of the respiratory system; pharmaceutical and biological preparations for medical purposes, namely the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and biological preparations for medical purposes, namely for the alleviation or prevention of pain or inflammation; pharmaceutical and biological preparations for medical purposes, namely, powders for asthma inhalers; pharmaceutical and biological preparations for medical purposes, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genitourinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purpose, namely, medicaments for inhalation therapy; pharmaceutical and biological preparations for medical purposes, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; pharmaceutical and biological preparations for medical purpose, namely medicaments for the treatment of erectile dysfunction, medicaments for the treatment of chronic obstructive pulmonary disease, medicaments for the treatment of premature ejaculation, medicaments for the treatment of cystic fibrosis, medicaments for the treatment of female sexual dysfunction, medicaments for the treatment of migraines, medicaments for the treatment of asthma


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79204968

Mark Type

No Service Mark

Attorney Docket Number

No AJO2-311-TM

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

26.17.06 -

Diagonal line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
30th Aug 2024CANCELLED SECTION 71
22nd Dec 2023NEW REPRESENTATIVE AT IB RECEIVED
13th Feb 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08th Oct 2022NEW REPRESENTATIVE AT IB RECEIVED
13th Jul 2018FINAL DECISION TRANSACTION PROCESSED BY IB
23rd May 2018FINAL DISPOSITION PROCESSED
23rd May 2018FINAL DISPOSITION NOTICE SENT TO IB
13th May 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13th Feb 2018REGISTERED-PRINCIPAL REGISTER
08th Dec 2017NOTIFICATION PROCESSED BY IB